Dr. Meteb Alfoheidi
Present Title and AffiliationMedical Oncology Consultant – Breast Cancer Sub-specialty
Princess Noorah Oncology Center – National Guard Health Affairs, Jeddah
Assistant Professor &
Medical Oncology Block Cordinator
King Saud Bin Abdulaziz University for Health and Science – Jeddah
Western Oncology Group Director
Saudi Oncology Society
Education2009-2010Breast Cancer Fellowship – University of British Columbia, Canada. 2007-2009Medical Oncology Residency Program (PGY 4-5) – University of British Columbia, Canada 2004-2007Internal Medicine Residency Program (PGY 1-3) – University of Toronto, Canada2000Bachelor Degree of Medicine and Surgery – King Faisal University, KSAExperienceMEDICAL ONCOLOGY2010 – PresentMedical Oncology, Breast Cancer Consultant, National Guard Health Affairs.2009 – 2010Breast Cancer Staff, British Columbia Cancer Centre, Canada.2007 – 2009Medical Oncology Resident, British Columbia Cancer Centre.2004 – 2007Internal Medicine Resident, University of Toronto, Canada.
ADULT MEDICINE2001 – 2004Resident, National Guard Health Affairs, Jeddah.
SOCIAL SHARE
Friday 3-5-2024 Day 1
Oncologists/pathologists dialogue TILS and descalation of systemic therapy in early breast cancer?
Moderator: Dr. Ahmed Alwbari Dr. Hatim Al Maghrabi
Friday 3-5-2024 Day 1
Transition from hormonal-based to chemotherapy in metastatic BC??
- Patients with early progression on CDK4-6 inhibitors: What is next??
- When to start ADCs/olaparib in patients who had visceral crisis?? Can be upfront??
- Any role of hormonal monotherapy after CDK4-6 inhibitors??
- Biomarkers to guide subsequent therapies
- Can we use one ADC after previous ADC??
Moderator: Dr. Ahmed Alfaraj
Panel: